(Q43687549)

25 November 2017

title

Efficacy and tolerability of interleukin-2 receptor blockade with basiliximab in pediatric renal transplant recipients (English)

1 reference

25 November 2017

U Vester

1

1 reference

25 November 2017

B Kranz

2

1 reference

25 November 2017

G Testa

3

1 reference

25 November 2017

M Malagò

4

1 reference

25 November 2017

D Beelen

5

1 reference

25 November 2017

C E Broelsch

6

1 reference

25 November 2017

P F Hoyer

7

1 reference

25 November 2017

publication date

1 August 2001

1 reference

Pediatric Transplantation

25 November 2017

published in

1 reference

25 November 2017

volume

5

1 reference

25 November 2017

issue

4

1 reference

25 November 2017

page(s)

297-301

1 reference

Randomised trial of basiliximab versus placebo for control of acute cellular rejection in renal allograft recipients. CHIB 201 International Study Group

25 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.2001.005004297.X

Neoral absorption profiling: an evolution in effectiveness.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.2001.005004297.X

Tacrolimus-based immunosuppression in pediatric renal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.2001.005004297.X

Clinical correlates of chronic rejection in pediatric renal transplantation. A report of the North American Pediatric Renal Transplant Cooperative Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.2001.005004297.X

7 January 2021

Reduction of the occurrence of acute cellular rejection among renal allograft recipients treated with basiliximab, a chimeric anti-interleukin-2-receptor monoclonal antibody. United States Simulect Renal Study Group

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.2001.005004297.X

7 January 2021

Risk factors for vascular thrombosis in pediatric renal transplantation: a special report of the North American Pediatric Renal Transplant Cooperative Study

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.2001.005004297.X

7 January 2021

End-stage renal failure in children younger than 6 years: renal transplantation is the therapy of choice

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.2001.005004297.X

7 January 2021

Mycophenolate mofetil as maintenance immunosuppression in pediatric renal transplantation

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.2001.005004297.X

7 January 2021

Analysis of hypertension in children post renal transplantation--a report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS)

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.2001.005004297.X

7 January 2021

Screening for basiliximab exposure-response relationships in renal allotransplantation

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.2001.005004297.X

7 January 2021

10.1034/J.1399-3046.2001.005004297.X

Identifiers

DOI

1 reference

25 November 2017

1 reference